Last updated: July 12, 2022
Sponsor: Hospital de Mataró
Overall Status: Active - Recruiting
Phase
N/A
Condition
Weight Loss
Lung Injury
Bronchitis (Pediatric)
Treatment
N/AClinical Study ID
NCT04581486
OMI
Ages > 70 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients aged 70 years or older.
- Diagnosed oropharyngeal dysphagia (signs of impaired efficacy and/or safety of swallowassessed with the V-VST).
- Giving written informed consent. In case of dementia or incapacitation, given consentby the nearest relative, main caregiver or legal representative.
Exclusion
Exclusion Criteria:
- Impaired safety of swallow with 5mL at high viscosity (800 mPa•s for NC).
- Severe dementia (Pfeiffer >6).
- Life expectancy less than 6 months.
- High functional dependence (Barthel index <40, preadmission).
- Dysphagia caused by anatomical alterations or by head and neck cancer or itstreatment.
- Patients going to nursing home or long-term care at discharge.
- Participation in any other studies involving investigational or marketed productswithin four weeks prior to start of the study.
- Investigator's uncertainty about the willingness or ability of the subject to complywith the protocol requirements.
- Patients with symptoms suggestive of COVID-19 or confirmed COVID-19.
Study Design
Total Participants: 500
Study Start date:
June 06, 2021
Estimated Completion Date:
June 30, 2023
Study Description
Connect with a study center
Consorci Sanitari del Maresme (Hospital de Mataró)
Mataró, Barcelona 08301
SpainActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.